Author: oncologs.com

The Vilcek Foundation announces the recipients of the 2024 Vilcek Foundation Prizes in Biomedical Science. Awarded annually since 2006, the prizes recognize outstanding immigrant scientists at the forefront of their fields, and celebrate the importance of immigrant contributions to scientific research and discovery in the

Rates of re-excision after initial breast-conserving surgery in women with breast cancer remain high across the United States, leading to an increased cost of care and a higher risk of postoperative complications, according to new research from UTHealth Houston. Credit: UTHealth Houston Rates of re-excision

In a global effort to improve the lives of breast cancer survivors, new leading health research has looked at strategies that can help prevent lymphoedema for millions of cancer survivors as a result of damage or removal of their lymph nodes during cancer treatment. Credit:

Epithelioid sarcoma, a rare aggressive cancer that usually strikes young adults, and rhabdoid tumors, which affect children, have long been difficult to treat. But the outlook for people with these subtypes of soft tissue sarcoma brightened in 2020 when the Food and Drug Administration approved a targeted therapy called tazemetostat (Tazverik™) for

Gastrointestinal cancers (GCs) are among the most common forms of cancer and account for as much as one-third of all cancer deaths worldwide. Early diagnosis is an effective way of reducing the mortality associated with GCs, and endoscopic screening has proved to be an excellent

A new computer program allows scientists to design synthetic DNA segments that indicate, in real time, the state of cells. Reported by the Gargiulo lab in “Nature Communications”, it will be used to screen for anti-cancer or viral infections drugs, or to improve gene and

Pancreatic cancer is the No. 3 cause of cancer-related deaths in the United States, and only 12% of patients survive five years after being diagnosed. Severe pancreatic cancer is associated with metastasis, and it is this spread of secondary tumors that usually causes death, but

Huntsman Cancer Institute at the University of Utah (the U) proudly introduces the first and only single-port robot in the Mountain West for head and neck surgical oncology patients. This state-of-the-art technology is a groundbreaking step in the field of oncological surgery, allowing for greater precision and less invasive

RICHLAND, Wash.—Doctors have nearly a dozen new targeted drugs to treat patients with acute myeloid leukemia, or AML, yet three of four patients still die within five years. Some patients succumb within just a month or two, despite the battery of drugs used to treat

A team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and the Urologic Tumours Unit of the Institut Català d’Oncologia (ICO) and the Germans Trias i Pujol Research Institute (IGTP) have found a new therapeutic strategy for patients with a specific subtype of metastatic